The team at Mills & Reeve LLP advises a varied client base of medical research charities, government bodies and fast-growing biotech and pharmaceutical companies, and the practice has ample experience in advising on tax, real estate, and IP matters. James Fry heads up the practice, often assisting clients with a broad range of contractual commercial issues. Fry also has broad expertise spanning research and technology collaborations, in addition to advertising and product classification work.
Legal 500 Editorial commentary
Key clients
- GSK
- Illumina
- CMR Surgical
- Neurocrine Biosciences
- F-star Therapeutics
- Sapphiros
- NRG Therapeutics
- PhoreMost
- Redx Pharma
- Calypso Biotech
- CMR Surgical
- Sanger Institute
- Wren Therapeutics
- Transition Bio
- MD Orthopaedics
- Haleon
- Kadans
- Sphere Fluidics
Work highlights
- Advising GSK on the divestment of Haleon plc and the cloning and renegotiation of commercial contracts (a mix of technology contracts, MSAs etc.).
- Advised F-star on its licence and collaboration agreement with Takeda. The agreement, which grants licences to Takeda of F-star’s proprietary platform IP relating to the generation of bi-specific antibodies, will facilitate research towards the development of a next generation immuno-oncology bispecific antibody.
- Represented MDO in the opposition of an application for a conflicting trade mark by a company associated with a former distributor.
Lawyers
Practice head
The lawyer(s) leading their teams.
James Fry